In our “Meet the Team” series, we highlight the talented individuals who drive Phastar’s success. Each team member brings unique skills, experience, and passion to their role, working together to deliver high-quality biometrics and data science solutions in clinical research. Below, we share their career journey, insights, and the impact they make every day.  Can you tell us a […]

Join us for a transformative three-part webinar series, “Driving Clinical Research with AI,” where industry leaders will discuss groundbreaking advancements in AI and its impact on clinical research. Hosted by Billy Amzal, Ph.D. , he will be joined by other Phastar speakers and prominent industry experts who will be announced soon.  This series will explore three […]

Join us for the next webinar in our causal inference series, focusing on how regulatory bodies are incorporating causal methods into decision-making. As expectations for robust, real-world evidence continue to grow, understanding how regulators evaluate causal analyses is becoming increasingly important. In this session, we will explore why causality matters, how agencies such as the […]

This webinar will cover methods that are crucial to making informed decisions. Specifically, personalized care through causal and federated learning, targeted maximum likelihood estimation (TMLE) and doubly robust methods.   Speakers: Ryan Batten, Senior Statistician, Phastar Julie Joss, Senior Researcher, Inria Josh Enxing, Senior Programmer, Phastar- Moderator Learning Points: Distinguishing correlation from causation in the […]

In our “Meet the Team” series, we highlight the talented individuals who drive Phastar’s success. Each team member brings unique skills, experience, and passion to their role, working together to deliver high-quality biometrics and data science solutions in clinical research. Below, we share their career journey, insights, and the impact they make every day.  Can you tell us a […]

Early-phase oncology combination trials often assume the optimal dose is already included in the dosing grid. When it isn’t, sponsors may face subtherapeutic or overly toxic recommendations, protocol amendments, and delays.  This white paper explores a contour-based method for inserting new dose combinations mid-trial, helping improve dose selection while maintaining safety and regulatory transparency.  What You’ll Learn  About the Author  Matt George, Senior Statistician, Phastar Specialist […]

As we mark B Corp Month 2026, Phastar is reaffirming its commitment to building a purpose-driven organization where people, sustainability, and community impact come first. Our approach to responsible business goes beyond compliance; it is embedded in how we support our employees, collaborate with partners, and contribute to the wider healthcare ecosystem.  Being a certified […]

Phastar is delighted to be exhibiting at the OCT Europe, 6-7 May in Barcelona, Spain. Visit the Phastar exhibit at booth #2 and learn more about our services.

Phastar is delighted to be attending PHUSE SDE, 15 May in Beijing, China. Connect to meet with our team on site or join our presentations: Introduction to AI SDK and Ink: Building Web and Terminal Apps with TypeScriptYong Cao, Senior Programming Manager13:30 – 14:00 Design and Analysis of a Multi-Frequency PRO Collection Strategy in a […]

In our “Meet the Team” series, we highlight the talented individuals who drive Phastar’s success. Each team member brings unique skills, experience, and passion to their role, working together to deliver high-quality biometrics and data science solutions in clinical research. Below, we share their career journey, insights, and the impact they make every day.  Can you tell us a […]

Phastar is delighted to be attending ISPOR US, 17-20 May in Philadelphia, PA Connect to meet with our team on site or stop by our posters: Evaluation of the Role of Clinical Unmet Need in Health Technology Assessment Decision-making of Oncology Trials Without Demonstrated Overall Survival Benefits Due to Treatment CrossoverPoster Session Date/Time: Monday, 18 […]

Progress in our industry is often measured in milestones, approvals, data readouts, and regulatory submissions. But behind every milestone are people.  This International Women’s Day, we’re taking a moment to spotlight some of the women across Phastar whose expertise, judgement, resilience and leadership shape our work every day. Not just in senior roles, and not just in visible moments, but across teams, disciplines, and career […]

Phastar is delighted to be attending CEN, 18-21 May in Warsaw, Poland. Connect to meet with our team on site and visit our presentations and poster. Presentations: Prognostic Models for Recurrent Event DataTuesday, 19 May, 10:45 – 12:15Victoria Watson, Senior Statistician I Bayesian Methods in Registered Clinical Trials: A Systematic Review of Studies on ClinicalTrials.gov […]

To mark International Women’s Day 2026, a new article in PharmaLive, authored by Sarah Tucker, Chief Operating Officer at Phastar, explores how visible, inclusive leadership and strong female representation across technical and executive teams are driving operational excellence, stronger decision-making, and improved outcomes in clinical research, while reinforcing the business case for diversity in a […]

Phastar is delighted to be attending the 2026 CDISC Europe Interchange 20-21 May in Milan, Italy Connect to meet with our team on site or join our presentation: Climbing Out of the Silos: Connecting CDISC Standards and Open-Source Tools for End-to-End AutomationWednesday 20 May, 2:30 – 3:00pmJohn McDade, Associate Director, Operational Excellence

Phastar is excited to be attending PharmaSUG US, 31May – 3 June in Boston, MA. Connect with us on site or visit our posters: %Compare_counts: A Macro for Speeding Up the QC Process When Proc Compare Slows It Down E-Poster Closing the Expectation Gap: A Leadership Framework for Clinical Programming SuccessCareer Development, Leadership & Soft […]

Phastar is delighted to be exhibiting at PSI in Belfast from 15th – 17th June 2026. Visit the Phastar team at Booth #9 and find out more about our solutions. Event chair: Vicky Marriott, Head of Statistics Presentations Academic-Industry Collaboration and ConnectionIan Wadsworth, Associate Director, StatisticsMonday, 15 June 2026, 13:30 – 14:15 Early Phase Clinical Trials […]

Phastar is excited to be attending BIO International, 22 – 25 June in San Diego, CA Visit us at booth #5957 to learn more about our solutions.

Phastar is excited to be attending the RSS 2026, 7-10 September in Bournemouth, UK. Connect with us to learn more about our solutions.

Phastar is excited to be attending the ASA Biopharmaceutical Section Regulatory-Industry Statistics Workshop from 16 -18 September in Rockville, MD. Connect with us or visit our booth to learn more about our solutions.

Phastar is excited to be attending OCT New England, 27 -28 October in Boston, MA. Connect with us or visit at booth #33A to learn more about our solutions.

Phastar is excited to be attending European Statistical Forum, 12 – 13 November in NH Budapest City, Budapest. Connect with us at our presentation or request a meeting below: Experiences of Utilizing the BOIN12 Method for Designing Rare/Small Population Oncology TrialsGiles Partington, Consultant Statistician13 November 2026

Can you tell us a bit about your background and what led you to join Phastar?   I hold an M.S. in Statistics and have almost 15 years of experience working on clinical trials across both CRO and pharmaceutical settings. I’ve contributed to numerous studies across different therapeutic areas, gaining extensive experience in study design, analysis, and data interpretation. I […]

Phastar is excited to be attending PHUSE EU Connect, 15 – 18 November in Glasgow, Scotland Connect with us or visit our booth to learn more about our solutions.

Causal inference is increasingly used to generate real-world evidence (RWE), by regulatory bodies and health technology assessment. This webinar introduces what is required to support causal claims, how causality can be evaluated across different study designs, and why this shift is particularly relevant for RWE today.   Speakers: Ryan Batten, Senior Statistician Josh Enxing, Senior Programmer- Moderator Learning Points: Distinguishing correlation from causation in the context of clinical and […]

In our “Meet the Team” series, we highlight the talented individuals who drive Phastar’s success. Each team member brings unique skills, experience, and passion to their role, working together to deliver high-quality biometrics and data science solutions in clinical research. Below, we share their career journey, insights, and the impact they make every day.  Can […]

In our “Meet the Team” series, we highlight the talented individuals who drive Phastar’s success. Each team member brings unique skills, experience, and passion to their role, working together to deliver high-quality biometrics and data science solutions in clinical research. Below, we share their career journey, insights, and the impact they make every day.  Can […]

As the pharmaceutical landscape evolves, traditional clinical trial designs are increasingly complemented by innovative, data-driven approaches. Real-world data (RWD) offers the potential to augment trials, simulate patient populations, and generate synthetic control arms. In-silico trials, powered by RWD and advanced analytics, help provide a path to faster, more efficient, and highly informative drug development. This […]

Use of external data to augment clinical trials has been increasingly evaluated and is transforming drug development paradigms.   Numerous innovative methods including hybrid designs, Bayesian borrowing and disease modeling have been developed, raising the new regulatory question: “Is the data we observe similar to the data we predicted or intended to include?”    The […]

The demand for rapid, cost-effective, and standards-compliant SDTM delivery continues to increase across the biotech and pharmaceutical industry. While company level SDTM standards and SAS macro-based solutions have fulfilled the needs for many years, they can still be restrictive and less adaptable in today’s evolving trial landscape and performance requirements.  This webinar series will discuss the practical […]

In our “Meet the Team” series, we highlight the talented individuals who drive Phastar’s success. Each team member brings unique skills, experience, and passion to their role, working together to deliver high-quality biometrics and data science solutions in clinical research. Below, we share their career journey, insights, and the impact they make every day.  Can […]

Introduction  Data Monitoring Committees (DMCs) play a pivotal role in protecting the rights, safety and well-being of trial participants and also the integrity of clinical studies. Central to their optimal effectiveness are Independent Data Analysis Centers (IDAC), which bring technical expertise, operational oversight, and strategic insight to every stage of the DMC process. By reading […]

The early stages of clinical development are critical, decisions made here can determine the efficiency, cost, and ultimate success of an entire program. With the evolving landscape of early phase drug development, sponsors need flexible yet robust statistical approaches to ensure that promising compounds are evaluated effectively and efficiently. Getting this stage right not only […]

Introduction A Data Monitoring Committee’s (DMC) overriding responsibility is to protect the rights, safety and well-being of trial participants. The optimal set-up and conduct of DMC meetings in clinical trials requires specialized expertise. It involves not only rigorous data review and oversight by the DMC members, but also meticulous attention to, where applicable, maintaining the […]

Real-world data (RWD) are transforming clinical research. By supplementing randomized controlled trials (RCTs), RWD can de-risk studies and improve generalizability. Innovative designs, from hybrid RCTs to registry-based trials, are gaining traction, with regulators setting clear standards for their use. This webinar shares case studies, practical methodologies, and key considerations to help you apply RWD effectively […]

In our “Meet the Team” series, we highlight the talented individuals who drive Phastar’s success. Each team member brings unique skills, experience, and passion to their role, working together to deliver high-quality biometrics and data science solutions in clinical research. Below, we share their career journey, insights, and the impact they make every day.  Can […]

Phastar, a global specialist biometrics & data science Contract Research Organization (CRO), has been named as finalists in two categories at the prestigious 2025 Scrip Awards. Phastar was recognized in the ‘Best Contract Research Organization – Specialist Providers’ and ‘Community Partnership of the Year’ categories at the 21st anniversary awards, which will be announced at […]

In our “Meet the Team” series, we highlight the talented individuals who drive Phastar’s success. Each team member brings unique skills, experience, and passion to their role, working together to deliver high-quality biometrics and data science solutions in clinical research. Below, we share their career journey, insights, and the impact they make every day.  Can you […]

Outsourcing clinical trial activities to specialist data-focused CROs is growing rapidly, driven by the need for expert data management, biostatistics, and faster time to market. These partnerships deliver cleaner, more reliable data, streamlined operations, and faster regulatory acceptance. In an article for International Clinical Trials, Stephen Corson, Associate Director, Statistics & Technical Solutions at Phastar […]

In ACRP Clinical Researcher, Katie Dixon, Senior Statistician at Phastar, reflects on the transition from graduate to manager and the support required for new leaders to thrive. “As outlined in my own experience, shadow-lead roles are one way organizations can support staff as they prepare to transition into management roles. Another effective intervention is the […]

In our “Meet the Team” series, we highlight the talented individuals who drive Phastar’s success. Each team member brings unique skills, experience, and passion to their role, working together to deliver high-quality biometrics and data science solutions in clinical research. Below, we share their career journey, insights, and the impact they make every day.  Can […]

Data Monitoring Committees (DMC) are a critical part of the clinical trial process, independently assessing the safety of an investigational product and at times the futility/efficacy. Successfully navigating DMC set-up, logistics, and independent data review can be complex, especially for biotech and smaller sponsors without in-house expertise.  Speakers: Lucy Clark, Statistics Manager Lisa Gibbons, Senior […]

Phastar recently welcomed Billy Amzal as Head of Strategic Consulting. A statistician, public health scientist, and entrepreneur, Billy brings more than 25 years of experience across the biotech and pharmaceutical industries, health agencies, and consulting.  His expertise lies in innovative, regulatory-grade statistical methodologies including adaptive trial designs, model-based meta-analysis, Bayesian approaches, and predictive modeling using […]

In our “Meet the Team” series, we highlight the talented individuals who drive Phastar’s success. Each team member brings unique skills, experience, and passion to their role, working together to deliver high-quality biometrics and data science solutions in clinical research. Below, we share their career journey, insights, and the impact they make every day.  Can […]

London, UK, and Durham (NC), US – June 24th, 2025: Phastar, a global specialist biometrics & data science Contract Research Organization (CRO), today announced the appointment of Billy Amzal as Head of Strategic Consulting. Amzal is a statistician, public health scientist, and entrepreneur with more than 25 years of experience across biotech and pharmaceutical industries, […]

As a follow-up to Clinical Trials Day 2025, with the theme of being “Powered By Purpose,” industry thought leaders shared their perspectives with ACRP on their clinical research powers, and on what they see as being the greatest current challenges and opportunities facing the field today. In June’s issue ACRP Clinical Researcher, Phastar’s Chief Operating […]

In our “Meet the Team” series, we highlight the talented individuals who drive Phastar’s success. Each team member brings unique skills, experience, and passion to their role, working together to deliver high-quality biometrics and data science solutions in clinical research. Below, we share their career journey, insights, and the impact they make every day.  Can […]

Sponsors working in rare diseases/running small population studies often have difficulties in demonstrating efficacy due to the small number of patients available for analyses. Bayesian methods offer promising solutions for small population and rare disease trials where leveraging available data can provide important insights and evidence. Discover the importance of Bayesian trial designs and the […]

Introduction  Patient reported outcomes (PRO) have been used in clinical trials for many years, but it is only recently that electronic (ePRO) collection has become possible. The advantage for trials is the potential for on-the-spot measurement of endpoints that are characterized as a set of symptoms, reportable by patients. This decentralized data collection has the […]

In this exclusive Discover Pharma interview, Sarah Tucker, Chief Operating Officer at Phastar, shares how the CRO is transforming clinical trials through flexible, data-driven delivery and patient-centric innovation. From decentralized models to Lean Six Sigma, she offers key insights into balancing speed with scientific rigor in today’s evolving trial landscape. ”As specialists in biometrics and […]

With major changes ahead for EU Health Technology Assessments (HTAs), including the introduction of joint clinical assessments from 2025, developers must adapt quickly to new regulatory expectations. In a recent article for PharmaPhorum, Stephen Corson, Associate Director, Statistics and Technical Solutions and Head of Statistical Consultancy at Phastar, outlines how developers can prepare for the […]

Real-world evidence (RWE) is rapidly transforming how clinical trials are designed, evaluated, and approved. In Phastar’s latest webinar, part of our new biotech-focused series, Principal Data Scientist Tasos Mangelis provided an in-depth look at the evolving RWE landscape, highlighting the opportunities, challenges, and practical applications of real-world data (RWD) in clinical development.  The Rise of […]

Phastar has been shortlisted for the Excellence in Clinical Trial Management category at the Fierce CRO Awards 2025. The award recognizes organizations that are redefining trial delivery through innovation, efficiency, and improved oversight. Our entry highlighted the impact of Phastar’s Clinical Intelligence platform, developed to support real-time oversight across complex trials by integrating operational, statistical, […]

In an exclusive feature for Contract Pharma, Phastar’s Head of Business Transformation and China General Manager, Ping-Chung Chang, examines how data sciences solutions including advanced analytics and data visualization are accelerating clinical development. He discusses the increasing complexity of clinical trials and how integrating real-time insights and AI-driven tools is transforming operations, enhancing recruitment, and […]

Introduction  Real-world data (RWD) plays a crucial role in medical research, providing valuable insights from a  variety of sources including electronic health records and claims databases. However, unlike randomized controlled trials, allocation is not random. This can result in confounding.   Understanding and addressing confounding is essential for valid causal inference. This blog post explores challenges […]

In our “Meet the Team” series, we highlight the talented individuals who drive Phastar’s success. Each team member brings unique skills, experience, and passion to their role, working together to deliver high-quality biometrics and data science solutions in clinical research. Below, we share their career journey, insights, and the impact they make every day.  Can […]

Introduction  In clinical research, selecting the most effective treatment can be challenging, especially when multiple options exist but direct head-to-head comparisons are limited. Network Meta-Analysis (NMA) is a powerful statistical technique that helps overcome this challenge by integrating both direct and indirect evidence to compare multiple treatments simultaneously.  This blog will introduce what NMA is, […]

Real World Evidence (RWE) plays a critical role across multiple pharma processes, including drug development, regulatory decision-making, precision medicine and health economics, providing valuable insights from actual clinical practice. In order to leverage these data effectively and make informed decisions, sponsors need to be aware of the types of data that are available and the […]

At Phastar, we are passionate about accelerating the pace of clinical development through specialist biometrics and data science solutions, supporting our clients in their mission to improve human health. But as we work with our clients to develop better treatments, it is important to reflect on the impact our industry has on the planet. From […]

Early-phase clinical trials play a critical role in drug development, particularly in determining the right dose and combination of treatments for later-stage testing. With the increasing complexity of combination therapies, traditional trial designs often struggle to keep pace.  In our recent webinar, Dr. Pavel Mozgunov (MRC Investigator, MRC Biostatistics Unit, University of Cambridge), Weishi Chen […]

In our “Meet the Team” series, we highlight the talented individuals who drive Phastar’s success. Each team member brings unique skills, experience, and passion to their role, working together to deliver high-quality biometrics and data science solutions in clinical research. Below, we share their career journey, insights, and the impact they make every day. Can […]

London, UK, and Durham (NC), US – April 10th, 2025: Phastar, a global specialist biometrics & data science Contract Research Organization (CRO), has been shortlisted in ‘CRO Partnership of the Year’ category at the 2025 Citeline Awards for its collaboration with Medicines Development for Global Health (MDGH), a not for profit pharmaceutical company dedicated to […]

In the evolving landscape of clinical trials, data monitoring has traditionally been a one-way street, data flows from electronic data capture (EDC) or other source data systems into dashboards for review, but user inputs into the data systems often require cumbersome manual processes. At Phastar, we’re building a future where clinical trial data portals function […]

In an interview with The Clinical Trial Vanguard, Phastar CEO Graham Clark explores the evolving pharmaceutical landscape. He shares insights on the latest industry trends, highlighting the growing role of technology in clinical trials and the strategic advancements shaping drug development and trial management.

As we celebrate B Corp Month, Phastar reaffirms its commitment to responsible business practices that drive real impact. We continue to drive sustainability through initiatives such as our net-zero targets, pro bono biometrics support for charities, and ESG-driven clinical trial solutions.  Additionally, we are proud to announce that Phastar has improved its CDP sustainability score, […]

As we mark International Women’s Day 2025, Phastar is calling for accelerated action toward gender equality in data and STEM fields. At the current pace, full gender parity won’t be reached until 2158, making it crucial for our industry to act now. While Phastar is proud that over 56% of our data experts are women, […]

On Rare Disease Day, we highlight the potential of Bayesian statistics to overcome recruitment challenges in rare disease trials. In an article for ACRP Clinical Researcher, Giles Partington, Principal Statistician at Phastar, explores how incorporating prior data and expert judgment can reduce sample size requirements, improve efficiency, and increase trial success rates. ”There are between […]

At SCOPE 2025, Phastar CEO Graham Clark spoke with Applied Clinical Trials (ACT) about the future of clinical trial optimization. Discussing Phastar’s Best in Show-winning Clinical Intelligence Portal, he highlighted how data science solutions such as AI-driven analytics and real-time insights are transforming trial oversight.  ” The first thing, the bedrock of everything, is rigorous data […]

London, UK, and Durham (NC), US – February 13th, 2025: Phastar, a global specialist biometrics & data science contract research organization (CRO), won a Best of Show Award at Summit for Clinical Ops Executives (SCOPE) US 2025. Having taken place in Orlando, Florida from the 3rd-6th February, SCOPE’s 300+ attendees voted on more than 60 product […]

Graham Clark, CEO at Phastar, spoke to PharmaVoice with his predictions on how AI and data science solutions will further transform the business of drug discovery and development this year. ”As AI, big data and digital health technologies become essential for trial design and patient recruitment, the demand for analytical and technical skills will likely […]

Graham Clark, CEO at Phastar, contributed to Clinical Research News on his predictions for clinical research in 2025. Clark highlighted the growing efficiency brought by AI but warned of a critical talent shortage in specialized roles like AI experts and data scientists. He urged the industry to upskill and adapt to new technologies to avoid […]

London, UK, and Durham (NC), US – December 9th, 2024: Phastar, a global specialist biometrics contract research organization (CRO), has won the Best CRO – Specialist Providers category at the 2024 Scrip Awards. Presented at Raffles London at the OWO on Wednesday, December 4th, Phastar was recognized for its high-quality, specialized biometrics solutions, advanced clinical […]

Having completed an undergraduate degree in mathematics, Sarah Crossley joined the Phastar apprenticeship scheme in January 2024, where they are currently pursuing a master’s degree while working as a statistician. This apprenticeship scheme is distinct from the Phastar graduate program, which is designed for individuals who have recently graduated from an MSc or PhD. In […]

Introduction Health Technology Assessments (HTA) are a vital process within healthcare systems, evaluating the value of medical interventions, such as drugs and medical devices, based on their clinical, economic, and ethical impacts. Traditionally, HTAs have been conducted on a national level across Europe, leading to significant variations in how health technologies are assessed and adopted […]

Elisa Mansfield, Vice President FSP at Phastar contributed an article to European Pharmaceutical Contractor discussing the rise of a FSP solution to outsourcing, the advantages to this method and how to select the right strategic partner to optimize outsourcing for the greatest efficiency, quality and flexibility. ‘Outsourcing allows sponsors to reduce costs, gain specific domain […]

Vicky Marriott, Head of Statistics at Phastar recently spoke with Outsourcing Pharma for its Women in Science feature. In the exclusive interview she discusses her career to date, the challenges she has faced and how she wants to inspire the next generation of women in statistics. ‘I also had a preconception that you needed to […]

We are proud to announce that Phastar has improved its EcoVadis sustainability score, achieving a commendable 60 this year. This progress places us within the top 35% of companies, earning a prestigious bronze rating.   EcoVadis is a trusted global provider of business sustainability ratings, helping organizations measure and improve their impact on society and the […]

Elisa Mansfield, Vice President, FSP at Phastar, contributed an article for the October issue of Applied Clinical Trials titled ‘Implementing a Gold Standard FSP Strategic Partnership’. The article discusses how biotech and biopharma companies can make sure they choose the right FSP solution to maximize financial efficiency, quality, operational effectiveness, and overall success. ‘In a […]

On this World Mental Health Day, Phastar stands in support of raising awareness and fostering open conversations about mental well-being. This year’s theme, “Time to Prioritize Mental Health in the Workplace,” underscores the critical importance of addressing mental health and well-being for the benefit of individuals, organizations, and communities.  At Phastar, we are dedicated to […]

Phastar’s Data Analytics and Visualization Portal and commitment to high ESG standards secures shortlist spot at the 20th Anniversary Scrip Awards London, UK, and Durham (NC), US – 24th September 2024: Phastar, global specialist biometrics contract research organization (CRO), has been named as a finalist for the Best Contract Research Organization – Specialist Providers category […]

Phastar continues to lead the CRO industry in corporate responsibility as CEO Graham Clark is named in list of trailblazers, innovators and visionaries. London, UK, and Durham (NC), US – 15th August 2024: Phastar, global specialist biometrics contract research organization (CRO), has been recognized in the 2024 Environment 100 List, led by Graham Clark. The award […]

In her article for BioSpectrumAsia, Professor Jennifer Visser-Rogers highlights ongoing gender inequality in the pharmaceutical industry, pointing out that despite women comprising over half of new entrants, they hold fewer leadership positions and face a significant pay gap, with stereotypes, biases, and childcare responsibilities hindering their career advancement. Prof Visser-Rogers points to solutions including awareness […]

High quality data visualisation and advanced recruitment forecasting app shapes success story in Best Sponsor Facing Initiative London, UK, and Durham (NC), US – 25th March 2024: Phastar, a global specialist biometrics contract research organization (CRO), has been selected as finalist for the Best Sponsor-facing Technology Initiative at the Citeline Awards 2024. Phastar were recognised for the launch of their Clinical Intelligence […]

In this article for PharmaPhorum, Phastar’s Stephen Corson’s delves into the changing landscape of Health Technology Assessments (HTAs) in Europe. With the introduction of the EU-wide HTA regulation, there’s a shift towards a unified approach to evaluating new therapeutic products and medical devices. This change aims to harmonize and streamline the post-regulatory approval adoption process […]

London, UK and Durham (NC), US – 7th March 2024. Prof Jennifer Visser-Rogers, Vice President, Statistical Research and Consultancy at Phastar, has today been announced as one of the Women in Data® Twenty in Data & Technology. The 6th series is a showcase of inspirational, trailblazing and dedicated women, encompassing every level of seniority and data […]

Complete the form below to watch the webinar Featuring: Moderated by Natalie Fforde, Senior Vice President, Global Strategic Partnerships, Phastar

In his article for Applied Clinical Trials, Ping-Chung Chang’s highlights the rapid evolution of clinical trials driven by the rise of Hybrid and Decentralized Clinical Trials (DCT). As clinical trials increasingly rely on technology for data collection, new challenges and opportunities emerge for the clinical research workforce. Read the full article in Applied Clinical Trials.

Presented by: LaRee Tracy, PhD, and Joshua Baker, PhD Complete the form below to watch the webinar

London, UK and Durham, NC – January 23rd, 2024: Phastar, a global specialist biometrics contract research organization (CRO), has announced the launch of Stats Helpdesk, a new initiative designed to provide biotech companies with free access to its team of expert statisticians. The Stats Helpdesk initiative offers essential support and guidance tailored to address the statistical questions […]

Season’s Greetings from the Phastar team! Each year Phastar holds an internal competition among its programmers to create a work of festive art, using only their imagination and SAS software! If you’d like to see how it all works , find the SAS code below: data xmas;%annomac;length style $200;vpos = 100;hpos = 105; green = […]

In her article for Applied Clinical Trials, Professor Jennifer Visser-Rogers explores the evolving relationship between contract research organizations (CROs) and sponsor partners in the pharmaceutical industry. She discusses how CROs have expanded their capabilities to support sponsors in various aspects of clinical trials, emphasizing the shift towards strategic partnerships and the increasing reliance on specialized […]

Supporting medicine development for disadvantaged communities London, UK, and Durham (NC), US – 26th October 2023: Phastar, a global specialist biometrics contract research organization (CRO) is offering pro bono support to Medicines Development for Global Health (MDGH), a not-for-profit organization developing medicines for neglected diseases primarily affecting people living in low- and middle-income countries. As […]

Phastar commits to achieving Net-Zero Standard by 2035 London, UK, and Durham (NC), US – 9th October 2023: Phastar, a global specialist biometrics contract research organization (CRO), has had its net-zero target approved by the Science Based Targets initiative (SBTi). The SBTi is a global body enabling businesses to set ambitious emissions reductions targets in […]

In this article for ICT Summer 2023, Professor Jennifer Visser-Rogers highlights the importance of collaborative efforts across the life sciences ecosystem to address the challenges facing modern healthcare. Read the full article in the International Clinical Trials/EPC’s Women in Pharma 2023 supplement.

Phastar Sets Course for Further Growth with New CEO Appointment London, UK and Durham (NC), US – 10th August 2023. Phastar, a global specialist biometrics contract research organization (CRO), today announced the appointment of Graham Clark as the new Chief Executive Officer. Amid ambitious growth plans and organizational changes, Clark will succeed Andrew MacGarvey as […]

We are absolutely delighted that Phastar is now a certified B Corporation®, effective from June 2023. We are proud to be a part of this community (covering 6,800 global companies) and to reaffirm our objective to lead the CRO industry in corporate social responsibility! What does it actually mean to be a B Corp™? B […]

International certification recognizes leading global specialist biometrics CRO’s commitment and leadership in corporate social responsibility and sustainable business practices. London, UK and Durham, NC – 11th July 2023. Phastar, a global specialist biometrics contract research organization (CRO), have become a certified B Corporation®. It comes after a stringent 12-month review to ensure protocols and procedures […]

Stephen Corson, Statistics Manager at specialist biometrics contract research organization (CRO) Phastar, has been chosen to receive the DIA 2023 Global Inspire Award for Community Engagement. This prestigious award recognises the outstanding contribution of DIA Community Chairs who consistently drive engagement and promote knowledge sharing, while advancing thought leadership within the membership community. Stephen commented: […]

London, UK and Durham, NC – April 13, 2023 – Phastar has supported a Great Ormond Street Hospital-sponsored study into new treatments for children with severe combined immunodeficiency (SCID). The company provided pro bono support from its specialist statisticians, data managers and programmers for the study, testing efficacy and safety of cryopreserved haematopoietic stem cells […]

London, UK and Durham, NC – January 10, 2023 – Phastar announced today the acquisition of S-Cubed ApS, a specialist biometrics and data visualisation company. The deal takes the Phastar group to around 550 people worldwide and strengthens the company’s position in the Nordic region. Andrew MacGarvey, CEO of Phastar, commented, “I am pleased we […]

London, UK and Durham, NC – 08 December, 2022 – Phastar, a global specialist biometrics contract research organization (CRO), has joined Lean Life Science’s Oncology Development Programme (ODP2). The targeted programme aims to identify and accelerate novel oncology innovations into commercially-attractive assets by offering support to academics and early-stage companies. In collaboration with top global […]

New pro-bono scheme allows charities to access Phastar’s biometrics experts at no cost London, UK and Durham, NC – November 5, 2022 – Phastar, a global specialist biometrics contract research organization (CRO), has announced the launch of a pro-bono scheme to give charities access to its volunteer statisticians, data scientists, data managers and programmers at […]

In recent years there has been a rising interest in the subject of mental health, and a growing understanding of the important role it plays in our everyday lives. Companies are increasingly expected to pay attention to the mental health needs of their staff, and where possible, to provide appropriate support. In the wake of […]

The experience across the team at Phastar is rich and varied and on average the technical team has over 14 years’ experience, which is a wealth of knowledge that brings huge benefits to our clients. The team are not only experts working with data but also the analytics of that data to deliver value. The […]

Beijing, China and London, UK, April 20, 2022 – Phastar, a global specialist biometrics contract research organization (CRO) offering industry leading data management, data science, statistical consulting, and clinical trial reporting services, today announces that Ping-Chung Chang has joined the company as Head of China Development and Global Delivery. Ping brings deep experience in CRO […]

London, UK and Durham, NC – 3 August 2021 – Phastar, a global specialist biometrics contract research organization offering industry leading data management, data science, statistical consulting and clinical trial reporting services, announced today the appointment of Chuck Gelb as Chief Commercial Officer. Holding an MBA in Pharmaceutical Management and an MA in Biotechnology, Chuck […]

FSP (Functional Service Provision) is fairly common in the United States and Europe, where many of the world’s leading pharmaceutical and biotechnology companies are located, but the term ‘FSP’ is not yet commonplace in Japan. Furthermore, FSP is not ‘mainstream’ in China either. Japanese-based pharmaceutical companies, including foreign companies, are mainly utilising a more orthodox […]

Functional Service Provision (FSP) and Full- Service outsourcing models have been hotly debated topics over the past decade. Of course, both have their places in the market however market share shifts between the two have certainly been observed. As service providers continue to match their offerings with customers’ wishes, hybrid models of FSP and Full-Service […]

Tokyo, Japan and London, UK – 23rd June 2020 –Phastar, a global CRO offering industry leading statistical consulting, clinical trial reporting, data management and data science services, announced today that the company has officially opened its Tokyo office. Phastar Tokyo will serve as a strategic operational hub to support our Japanese partners and is a […]

I started out my university experience by going to Dundee to study mathematics, this was mainly a theoretical degree with the occasional statistic module in the first two years. Once I was in my fourth year, I decided I wanted to focus on the more practical aspect of mathematics. After looking around I found this […]

Starting a career in industry can be a daunting experience at any time of life, but especially when it is your first full time job. Going from being a full-time student and enjoying the student life is very different to experiencing the 9-5 day job. From my time so far, I believe that the first […]

I am now one year into my graduate role at Phastar, and it has been one of the quickest years of my life. I joined Phastar after graduating from the University of Strathclyde with a Masters’ degree in Mathematics and Statistics. I sought a job where I would be challenged, and I was not going […]

Durham, NC and London, UK – December 4, 2019 – Phastar, a global CRO, has gained its 2020 Star rating based on the Best Companies’ Index score. Best Companies is a UK organization which sets accreditation standards for workplace engagement. PHASTAR’s score was derived from a survey conducted by Best Companies, which sets awards based […]

Phastar have attended a reception at Buckingham Palace for winners of the 2019 Queen’s Award for Enterprise. The company was awarded for excellence in the International Trade category following exponential growth from a one-person operation in 2007, to a global CRO with offices in four continents within the space of one decade. Around 300 people […]

London, UK and Cambridge, MA – June 24, 2019 – Phastar announced today that it has entered into a technology partnership with Medidata Solutions, Inc.. Phastar will deploy several solutions from the Medidata Rave Clinical CloudTM including Rave EDC, Coder, eCOA, and RTSM. The adoption of the Medidata Rave Clinical Cloud comes as Phastar continues […]

London, UK and Cambridge, MA – June 21, 2019 – Phastar, a global CRO, announced today that it will establish new offices in Tokyo and West Coast, US in 2020. Recruitment has already started for staff in the new offices which will serve as operational hubs for customers in Japan and the West Coast of […]

Phastar is delighted to be announced today as winners of the highly coveted Queens Award for Enterprise, in the International Trade category! Phastar’s win was down to its excellence in international trade and its exponential growth from a one-person operation in 2007, to a global CRO with offices in four continents within the space of […]

On Tuesday 24th July 2018, Phastar presented a webinar on the topic ‘Efficiencies when delivering a quality database’. The presenters were Sheelagh Aird, Head of Clinical Data Operations and Gillian Childs, Principal Data Coordinator. The webinar, hosted by X-talks and Medrio, demonstrated the importance of controlling the quality of a database right from study set-up. […]

Phastar, the global CRO offering statistical consulting, clinical trial reporting and data management services to the pharmaceutical and biotech industries, is delighted to be announced as winners of the inaugural award for Innovation in the Management of Clinical Data at this years ACDM Conference. The annual awards were established in 2019 to further showcase the […]

London, UK and Durham, NC – January 5 2021 – Phastar, a specialist biometrics clinical research organization (CRO) for clinical trials, announces an investment made by Charterhouse Capital Partners LLP, a long-established European private equity firm, which will support Phastar’s growth in biometrics and geographic expansion. Charterhouse is making its investment in partnership with PHASTAR’s […]

Phastar is delighted to have been shortlisted for the 2018 SCRIP Award in the category: Best Contract Research Organization – Specialist Provider. For the third year in succession, Phastar has been recognised for its success in delivering high quality statistical consulting, clinical trial reporting and data management. Now in its 14th year, the Scrip Awards […]

Phastar ranks inside the FT 1000! Recognising Phastar’s continued success, the company has recently been included as one of this year’s Europe’s 1000 Fastest Growing Companies. Phastar was featured in the Financial Times supplement on 7th April 2017 (see here) once again acknowledging Phastar’s accomplishments over recent years, growing into a successful provider of statistical […]